Hikma Pharmaceuticals PLC
OTC:HKMPY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hikma Pharmaceuticals PLC
OTC:HKMPY
|
UK |
|
RLX Technology Inc
F:3CM
|
CN |
|
Seibu Holdings Inc
F:0H9
|
JP |
|
Highcom Ltd
F:X9L0
|
AU |
|
E
|
Evonik Industries AG
OTC:EVKIF
|
DE |
|
S
|
Synlait Milk Ltd
OTC:SMLKF
|
NZ |
|
Inogen Inc
NASDAQ:INGN
|
US |
|
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
BR |
|
Samudera Shipping Line Ltd
SGX:S56
|
SG |
|
F
|
Flughafen Wien AG
VSE:FLU
|
AT |
|
G
|
Great Plains Metals Corp
XTSX:GPS
|
CA |
|
Enstar Group Ltd
F:48R
|
BM |
|
Aisin Corp
OTC:ASEKF
|
JP |
|
G
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
OTC:GZPHF
|
CN |
|
A
|
Atlassian Corp
SWB:48D
|
AU |
|
J
|
JSW Infrastructure Ltd
BSE:543994
|
IN |
|
Canadian Apartment Properties Real Estate Investment Trust
F:0OJ
|
CA |
|
K
|
Krynica Vitamin SA
WSE:KVT
|
PL |
|
T
|
Techtronic Industries Co Ltd
SWB:TIB1
|
HK |
|
V
|
Victorian Plumbing Group PLC
LSE:VIC
|
UK |
|
Four Corners Property Trust Inc
F:4Z1
|
US |
Dividends
Dividend Yield
Hikma Pharmaceuticals PLC
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Hikma Pharmaceuticals PLC
HKMPY have increased by 144%.
Payout Ratio
Hikma Pharmaceuticals PLC
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
HKMPY is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
HKMPY Price
Hikma Pharmaceuticals PLC
| Average Annual Return | -3.91% |
| Standard Deviation of Annual Returns | 23.86% |
| Max Drawdown | -61% |
| Market Capitalization | 3.5B USD |
| Shares Outstanding | 111 595 889 |
| Percentage of Shares Shorted |
N/A
|